Canaccord Genuity Upgrades RTI Biologics (RTIX) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Craig-Hallum Upgrades RTI Biologics (RTIX) to Buy
April 25, 2014 8:12 AM EDTCraig-Hallum upgraded RTI Biologics (NASDAQ: RTIX) from Hold to Buy with a price target of $5.00.
For an analyst ratings summary and ratings history on RTI Biologics click here. For more ratings news on RTI Biologics click here.
Shares of RTI Biologics closed at $3.93 yesterday.
... MoreRTI Biologics, Inc. (RTIX) Tops Q1 EPS by 2c; Boosts Outlook
April 24, 2014 8:12 AM EDTRTI Biologics, Inc. (NASDAQ: RTIX) reported Q1 EPS of $0.01, $0.02 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $60.7 million versus the consensus estimate of $55.4 million.
RTI Biologics, Inc. sees FY2014 EPS of $0.07-$0.09, versus prior guidance of $0.06-$0.08 and... More



